Artificial Intelligence In Epidemiology Global Market Report 2024 Global Market Analysis, Trends, Growth, Research And Forecast 2033

The new report published by The Business Research Company, titled Artificial Intelligence In Epidemiology Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the artificial intelligence in epidemiology market size has grown exponentially in recent years. It will grow from $0.52 billion in 2023 to $0.67 billion in 2024 at a compound annual growth rate (CAGR) of 29.3%. The artificial intelligence in epidemiology market size is expected to see exponential growth in the next few years. It will grow to $1.86 billion in 2028 at a compound annual growth rate (CAGR) of 29.2%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=12687&type=smp

Addressing The Chronic Disease Challenge Artificial Intelligence In Epidemiology
The growing burden of chronic diseases is expected to propel the growth of artificial intelligence in the epidemiology market going forward. Chronic disease refers to a health condition or disease that is persistent or long-lasting in its effects, usually lasting for three months or longer, and may get worse over time. AI plays a significant role in various aspects of chronic disease epidemiology, including risk prediction, disease progression modeling, early detection, and diagnosis. For instance, in May 2023, according to The United Nations (UN), a US-based intergovernmental organization to promote international cooperation and maintain international peace and security, Chronic diseases are responsible for seven out of 10 deaths in the US, killing more than 1.7 million Americans each year. Therefore, the growing burden of chronic diseases is expected to propel the growth of artificial intelligence in the epidemiology market.

Innovative Ai-Driven Imaging Platforms Transforming Disease Management In Epidemiology
Specialized AI-based technologies in disease management are a key trend gaining popularity in the artificial intelligence in epidemiology market. Major companies operating in the artificial intelligence in epidemiology market are concentrating on creating innovative technologies, such as AI-driven imaging platforms for disease management, to sustain their position in the market. For instance, in April 2023, Twinn.health, a US-based company engaged in fitness, AI, and machine learning, launched an AI-driven imaging platform for the early detection of age-related diseases. The new platform is the first to incorporate magnetic resonance imaging (MRI) data for the risk evaluation of frailty. It is a potent tool for early intervention and prevention since it detects chronic age-related disorders earlier than conventional molecular signals and helps manage these conditions at an early stage.

The artificial intelligence in epidemiology market covered in this report is segmented -

1) By Component: Software, Services
2) By Deployment: Web-Based, Cloud-Based
3) By Application: Infection Prediction And Forecasting, Disease And Syndromic Surveillance
4) By End-Use: Government And State Agencies, Research Laboratories, Pharmaceutical And Biotechnology Companies, Healthcare Providers

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=12687&type=discount

Major companies operating in the artificial intelligence in epidemiology market report are Apple Inc., Alphabet Inc., Microsoft Corporation, Facebook Inc., Roche Holding AG, Pfizer Inc., Johnson & Johnson Services Inc., Amazon Web Services Inc., General Electric Company, Google LLC, Intel Corporation, IBM Corporation, Merck & Co. Inc., Novartis International AG, Sanofi S.A, Bristol Myers Squibb Company, AstraZeneca PLC, Oracle Corporation, GlaxoSmithKline plc, NVIDIA Corporation, Bayer Healthcare, Siemens Healthineers AG, Cogniant Technology Solutions Corporation, Koninklijke Philips N.V., SAS Institute Inc., Epic Systems Corporation, Cerner Corporation, eClinicalWorks LLC, Meditech, Komodo Health, Metabiota Inc.

Contents of the report:
1. Executive Summary
2. Artificial Intelligence In Epidemiology Market Report Structure
3. Artificial Intelligence In Epidemiology Market Trends And Strategies
4. Artificial Intelligence In Epidemiology Market - Macro Economic Scenario
5. Artificial Intelligence In Epidemiology Market Size And Growth
…..
27. Artificial Intelligence In Epidemiology Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-epidemiology-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.